Topoisomerase IIα Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of CALGB 8541/150013
- Citation:
- J Clin Oncol vol 27 (21) 3430-3436
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- P30 CA016672
- Corr. Author:
- Authors:
- Lyndsay N. Harris Gloria Broadwater Maysa Abu-Khalaf David Cowan Ann D. Thor Daniel Budman Constance T. Cirrincione Donald A. Berry Eric P. Winer Clifford A. Hudis Daniel F. Hayes Paula Friedman Matthew Ellis Lynn Dressler
- Networks:
- Study
- CALGB-150013
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8541
- Phases:
- N/A, 3
- Keywords:
- Bios3, Bios4, Bc5, Bc8, To2, To3, ORIGINAL REPORTS, Breast Cancer